Literatur
Ross R (1999) Atherosclerosis—an inflammatory disease. n Engl J Med 340:115–126
Mughal MM, Khan MK, DeMarco JK, Majid A, Shamoun F, Abela GS (2011) Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther 9:1315–1330
Drummond GR, Sobey CG (2014) Endothelial NADPH oxidases: which NOX to target in vascular disease? Trends Endocrinol Metab 25:452–463
Brandes RP, Weissmann N, Schroder K (2014) Nox family NADPH oxidases: molecular mechanisms of activation. Free Radic Biol Med 76:208–226
Xu S, Chamseddine AH, Carrell S, Miller FJ Jr. (2014) Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques. Redox Biol 2:642–650
Tomczyk M, Kraszewska I, Dulak J, Jazwa-Kusior A (2019) Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase‑1. Vascul Pharmacol 112:79–90
Campbell NK, Fitzgerald HK, Dunne A (2021) Regulation of inflammation by the antioxidant haem oxygenase 1. Nat Rev Immunol 21:411–425
Hofmann A, Muglich M, Wolk S, Khorzom Y, Sabarstinski P, Kopaliani I, Egorov D, Horn F, Brunssen C, Giebe S, Hamann B, Deussen A, Morawietz H, Poitz DM, Reeps C (2021) Induction of heme oxygenase‑1 is linked to the severity of disease in human abdominal aortic aneurysm. J Am Heart Assoc 10:e22747
Calay D, Mason JC (2014) The multifunctional role and therapeutic potential of HO‑1 in the vascular endothelium. Antioxidants Redox Signal 20:1789–1809
Lin P, Ji HH, Li YJ, Guo SD (2021) Macrophage plasticity and atherosclerosis therapy. Front Mol Biosci 8:679797
Italiani P, Boraschi D (2014) From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 5:514
Boyle JJ, Harrington HA, Piper E, Elderfield K, Stark J, Landis RC, Haskard DO (2009) Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol 174:1097–1108
Andersen CB, Torvund-Jensen M, Nielsen MJ, de Oliveira CL, Hersleth HP, Andersen NH, Pedersen JS, Andersen GR, Moestrup SK (2012) Structure of the haptoglobin-haemoglobin complex. Nature 489:456–459
Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY (1998) Expression of heme oxygenase‑1 in atherosclerotic lesions. Am J Pathol 152:711–720
Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, Serruys PW, Duckers HJ (2009) Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119:3017–3027
Ijas P, Nuotio K, Saksi J, Soinne L, Saimanen E, Karjalainen-Lindsberg ML, Salonen O, Sarna S, Tuimala J, Kovanen PT, Kaste M, Lindsberg PJ (2007) Microarray analysis reveals overexpression of CD163 and HO‑1 in symptomatic carotid plaques. Arterioscler Thromb Vasc Biol 27:154–160
Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349:2316–2325
Vijayan V, Wagener F, Immenschuh S (2018) The macrophage heme-heme oxygenase‑1 system and its role in inflammation. Biochem Pharmacol 153:159–167
Landis RC, Philippidis P, Domin J, Boyle JJ, Haskard DO (2013) Haptoglobin genotype-dependent anti-inflammatory signaling in CD163(+) macrophages. Int J Inflam 2013:980327
Boyle JJ (2012) Heme and haemoglobin direct macrophage Mhem phenotype and counter foam cell formation in areas of intraplaque haemorrhage. Curr Opin Lipidol 23:453–461
Guo L, Akahori H, Harari E, Smith SL, Polavarapu R, Karmali V, Otsuka F, Gannon RL, Braumann RE, Dickinson MH, Gupta A, Jenkins AL, Lipinski MJ, Kim J, Chhour P, de Vries PS, Jinnouchi H, Kutys R, Mori H, Kutyna MD, Torii S, Sakamoto A, Choi CU, Cheng Q, Grove ML, Sawan MA, Zhang Y, Cao Y, Kolodgie FD, Cormode DP, Arking DE, Boerwinkle E, Morrison AC, Erdmann J, Sotoodehnia N, Virmani R, Finn AV (2018) CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis. J Clin Invest 128:1106–1124
Bengtsson E, Hultman K, Edsfeldt A, Persson A, Nitulescu M, Nilsson J, Goncalves I, Bjorkbacka H (2020) CD163+ macrophages are associated with a vulnerable plaque phenotype in human carotid plaques. Sci Rep 10:14362
Boyle JJ, Johns M, Lo J, Chiodini A, Ambrose N, Evans PC, Mason JC, Haskard DO (2011) Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 31:2685–2691
Etzerodt A, Moestrup SK (2013) CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxidants Redox Signal 18:2352–2363
Funes SC, Rios M, Fernandez-Fierro A, Covian C, Bueno SM, Riedel CA, Mackern-Oberti JP, Kalergis AM (2020) Naturally derived heme-oxygenase 1 inducers and their therapeutic application to immune-mediated diseases. Front Immunol 11:1467
Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583–650
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
B. Hamann, A. Hofmann, S. Wolk, A. Busch und C. Reeps geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Hamann, B., Hofmann, A., Wolk, S. et al. Die Rolle des Hämoxygenase-1-CD163-Signalweges bei atherosklerotischen Gefäßerkrankungen. Gefässchirurgie 27, 125–128 (2022). https://doi.org/10.1007/s00772-022-00868-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00772-022-00868-3